Global fibrinolytic therapy market is estimated to be valued at US$ 34.96 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period 2023 to 2030. Fibrinolytic therapy, also known as thrombolysis, involves the administration of clot-busting drugs to dissolve blood clots that form inside arteries and veins due to cardiovascular diseases such as myocardial infarction, pulmonary...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian